Search PubMed⌕ Search

Biomedical subjects

M Post

Publications and source records attributed to M Post.

At least 109 records · Page 6Linked to original sources

Inhibition of mechanical strain-induced fetal rat lung cell proliferation by gadolinium, a stretch-activated channel blocker.

Normal growth of the fetal lung is dependent upon fetal breathing movements. We have previously demonstrated that mechanical strain, simulating fetal breathing movements, stimulated DNA synthesis and cell division by reaggregated alveolar-like structures of fetal rat lung cells. Herein, we report that both intracellular and extracellular calcium modulate strain-induced proliferative activity. Strain-induced cell proliferation was inhibited by BAPTA/AM, an intracellular calcium chelator. The intracellular calcium modulators, cyclopiazonic acid and 2,5-di-(tert-butyl)-1,4-benzohydroquinone, increased DNA synthesis of unstrained cultures and partially reduced strain-induced cell growth activity. A similar effect was noted with the calcium ionophore A23187. Extracellular Ca2+ increased DNA synthesis in unstrained cultures in a concentration-dependent fashion. The stimulatory effect of strain on DNA synthesis was also dependent on the calcium concentration in the medium. Furthermore, strain-enhanced DNA synthesis was inhibited by the presence of a divalent ion chelator, EGTA, in the medium. Mechanical strain increased 45Ca2+ influx within 1 min after the onset of strain. This rapid entry of calcium was not affected by calcium channel blockers, such as verapamil or Ni2+. Calcium channel blockers verapamil, nifedipine, Ni2+, Co2+, or La3+ also did not inhibit strain-induced cell growth activity. In contrast, gadolinium, a stretch-activated channel blocker, inhibited strain-induced 45Ca2+ influx and suppressed strain-enhanced DNA synthesis. We conclude that the entry of calcium into cells through stretch-activated ion channels plays a critical role in strain-induced fetal lung cell proliferation.

Animals↗

Differential regulation of platelet-derived growth factor genes in fetal rat lung fibroblasts.

There is increasing evidence to suggest that platelet-derived growth factor (PDGF), or PDGF-like molecules, play a role in fetal lung morphogenesis. The cellular sources of PDGF and its target cells within the fetal lung remain to be defined. In the present study, we investigated the developmental expression of PDGF and its cognate receptor genes in fetal rat lung fibroblasts. Northern analysis revealed that fetal lung fibroblasts express the PDGF A-chain, B-chain, and beta-receptor genes. The cells actively translated these mRNAs into protein as demonstrated by immunocytochemistry and by metabolic labeling with [35S]methionine, followed by immunoprecipitation with specific PDGF-AA and -BB antibodies. Affinity cross-linking with 125I-labeled PDGF-BB demonstrated the presence of PDGF beta-receptors on fetal lung fibroblasts. The development expression of the PDGF genes was examined in fibroblasts derived from the early canalicular (Day 19) to the early saccular stage (Day 21) of lung development (term = 22 days). PDGF A-chain gene expression was at a low but constant level during late gestation. No change in either the transcription rate or stability of the message for this gene was observed with advancing gestation. Despite these mRNA observations, PDGF-AA is the major secreted form in the medium of the fibroblasts. Expression of PDGF B-chain gene was greatest during the early canalicular stage (Day 19) and declined sharply thereafter. The greater expression of PDGF B-chain during the canalicular stage was due to a greater rate of transcription and a greater PDGF B-chain mRNA stability. The PDGF beta-receptor gene was expressed at a lower but constant level in these cells during late gestation. The constant level of PDGF beta-receptor mRNA could be attributed to a balanced increased synthesis of the message coupled to an increased breakdown of the transcript. These data indicate that fetal lung fibroblasts synthesize PDGF-AA, PDGF-BB, and PDGF beta-receptor and that they regulate the developmental expression of these PDGF genes differently.

Animals↗

Increased expression of CTP:phosphocholine cytidylyltransferase in maturing type II cells.

We previously reported that phosphatidylcholine synthesis increased in fetal rat lung type II cells with advancing gestation. This increase was accompanied by an increase in CTP:phosphocholine cytidylyltransferase activity, which catalyses a rate regulatory step in de novo phosphatidylcholine synthesis by fetal type II cells. To determine whether this increase in cytidylyltransferase activity is due to an increase in cytidylyltransferase protein levels, the gene and protein expression of cytidylyltransferase was investigated in maturing type II cells. The cytidylyltransferase cDNA was cloned from fetal rat type II cells and showed 99% sequence homology with rat liver cDNA. The cDNA detected two mRNA transcripts (1.8 and 7.5 kb) in fetal rat lung. By reverse-transcriptase polymerase chain reaction (RT-PCR) analysis, cytidyltransferase mRNA content increased three-fold in fetal type II cells with advancing gestation, whereas cytidylyltransferase mRNA levels in fibroblasts remained constant. An antibody against rat liver cytidylyltransferase was used to assess cytidylyltransferase protein. Western blotting revealed that cytidylyltransferase protein content increased threefold in the microsomal fraction of type II cells with advancing gestation. The enzyme protein levels in the cytosolic fraction did not significantly change with development. Enzyme activity studies confirmed these latter observations. We conclude that the increase in surfactant phosphatidylcholine synthesis by type II cells at late fetal gestation is due in part to an increase in the amount of cytidylyltransferase protein.

Animals↗

Functional and biochemical assessment of postpreservation lung viability in a rat model.

We examined the relationship between DNA synthesis and postpreservation lung hemodynamics and gas exchange. Adult male Wistar rats (n = 168) were randomly allocated into seven groups (n = 24) according to the pulmonary vascular flush used [EuroCollins (EC), saline, or no flush] and to the temperature of flush and storage (4, 21, or 37 degrees C). In each group, lungs were stored for four different time periods (0-24 h). After storage, incorporation of [3H]-thymidine into DNA was measured in the right lung, and in 72 rats the left lung was reperfused for 1 h with venous blood in an ex vivo paracorporeal rat lung system. Autoradiography of EC lungs revealed that alveolar macrophages and epithelial cells were the two major cell types synthesizing DNA during ischemia. Gas exchange after preservation with EC was universally poor. In unflushed and saline-flushed lungs, a critical threshold for viability was detected beyond which DNA synthesis and lung effluent PO2 decreased more rapidly at higher storage temperatures. A positive correlation was found between the final lung effluent PO2 and [3H]thymidine uptake (R2 = 0.62; P < 0.0001). In this model, deoxyribonucleic acid synthesis was a good index of postpreservation hemodynamics and gas exchange function.

Animals↗

Expression of surfactant proteins in embryonic rat lung.

Because surfactant proteins A, B, and C (SP-A, SP-B, and SP-C) are putative markers for alveolar epithelial type II cells, we investigated their expression in embryonic rat lung (12 to 15 days, term = 22 days). The expression of the messages for SP-A, SP-B, and SP-C was assessed by the reverse-transcriptase polymerase chain reaction (RT-PCR). Embryonic rat lung at 12 days' gestation lacked detectable mRNAs for all three surfactant proteins. Messages for SP-A, SP-B, and SP-C were, however, present in embryonic rat lung at 13 days' gestation. Expression of SP-A mRNA increased in embryonic rat lung with advancing gestation. Surfactant protein mRNA expression during the embryonic period of lung development was limited to the epithelial cells. The expression of SP-A mRNA, while limited to the lung, did not appear to be a marker for cells destined to become type II cells, since it was detected in the trachea and the presumptive main bronchial ducts of embryonic rat lung at 13 days' gestation, as well as in the distal lung prealveolar region. Expression of both SP-B and SP-C mRNAs in embryonic lung was confined to the distal portion of the ductal system, although message of SP-C was also found in brain and kidney. These results suggest that none of the three surfactant protein mRNAs studied are, at this early stage of lung development, specific for cells destined to become type II pneumocytes.

Animals↗

Ontogeny and regulation of platelet-derived growth factor gene expression in distal fetal rat lung epithelial cells.

Using flow cytometry, thymidine uptake into DNA, and expression of two growth-related genes, histone 3 and c-myc, we found an increase in the proportion of distal lung epithelial cells in the G0/G1 phase of the cell cycle with advancing gestation. Since our previous studies had demonstrated that platelet-derived growth factor (PDGF) is essential for the progression of these cells from the G0/G1 to the S phase of cell cycle, we investigated the gene and protein expression of PDGF-related genes (PDGF-A, PDGF-B, alpha-receptor, and beta-receptor) in distal fetal lung epithelial cells. The cells transcribed all the PDGF-related genes and translated the PDGF-A and PDGF-B mRNAs into protein, as demonstrated by immunocytochemistry and immunoprecipitation. To explore an autocrine role for PDGF in distal fetal lung epithelial cells, intervention studies using PDGF-A and -B chain-specific antisense oligodeoxynucleotides (ODN) were carried out. Antisense PDGF-B ODN, but not antisense PDGF-A ODN, significantly reduced the DNA synthesis of these cells. The inhibitory effect of antisense PDGF-B ODN on DNA synthesis was reversed by the addition of exogenous PDGF-BB, which supports an autocrine role in the DNA synthesis of these cells. We also examined the expression of PDGF genes in distal fetal lung epithelial cells during late gestation. PDGF-A chain and beta-receptor gene expressions declined with advancing gestation, whereas expression of message for PDGF-B chain and alpha-receptor increased. The increases in message for PDGF-B chain and alpha-receptor with advancing gestation were due to a greater rate of transcription, whereas the developmental decrease of PDGF-A chain and beta-receptor mRNAs was caused by a decrease in RNA stability. Taken together with the ODN data, these results suggest that the G0/G1 cell cycle arrest of distal lung epithelial cells during late fetal gestation is due to a decrease in PDGF beta-receptor expression by the cells.

Animals↗

A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.

The activin and TGF-beta type II receptors are members of a separate subfamily of transmembrane receptors with intrinsic protein kinase activity, which also includes the recently cloned TGF-beta type I receptor. We have isolated and characterized a cDNA clone (C14) encoding a new member of this subfamily. The domain structure of the C14-encoded protein corresponds with the structure of the other known transmembrane serine/threonine kinase receptors. It also contains the two inserts in the kinase domain that are characteristic for this subfamily. Using in situ hybridization, C14 mRNA was detected in the mesenchymal cells located adjacent to the müllerian ducts of males and females at day 15 (E15) of embryonic development. Marked C14 mRNA expression was also detected in the female gonads. In female E16 embryos, the C14 mRNA expression pattern remained similar to that in E15 embryos. However, in male E16 embryos C14 mRNA was detected in a circular area that includes the degenerating müllerian duct. The expression of C14 mRNA was also studied using RNase protection assays. At E15 and E16, C14 mRNA is expressed in the female as well as in the male urogenital ridge. However, at E19, a high C14 mRNA level in the female urogenital ridge contrasts with a lack of C14 mRNA in the male urogenital ridge. This correlates with the almost complete degeneration of the müllerian ducts in male embryos at E19. C14 mRNA expression was also detected in embryonic testes at E15, E16 and E19 using RNase protection assays, but at much lower levels than those found in the developing ovaries.(ABSTRACT TRUNCATED AT 250 WORDS)

Activin Receptors↗

Antisense oligodeoxynucleotides targeting PDGF-B mRNA inhibit cell proliferation during embryonic rat lung development.

There is increasing evidence to suggest that platelet-derived growth factor (PDGF) or PDGF-like molecules play a role in fetal lung morphogenesis. Our previous studies demonstrated the presence of PDGF-AA and PDGF-BB homodimers in embryonic and fetal rat lung. To explore further the role for PDGF-BB in embryonic lung development, we conducted intervention studies using PDGF-B chain-specific antisense oligodeoxynucleotides in a simple embryonic rat lung explant system. Unmodified antisense PDGF-B oligodeoxynucleotides inhibited, in a concentration-dependent manner, DNA synthesis of embryonic lung. A maximal inhibition of 50% was observed. The inhibitory effect of antisense PDGF-B oligodeoxynucleotides on DNA synthesis was reversed by the addition of exogenous PDGF-BB but not PDGF-AA. Antisense treatment decreased PDGF-BB but not PDGF-AA protein content, as assessed by immunoblot analyses. Incubation of lung explants with PDGF-BB neutralizing antibodies also resulted in an inhibition of DNA synthesis. Morphometric analyses of antisense-treated cultures showed a significant reduction in lung size when compared to control cultures. The epithelial component of the embryonic lungs was specifically reduced, both in mass and DNA labelling index, by antisense treatment. The number of terminal buds of the lung explants was not significantly affected by antisense PDGF-B treatment. Scrambled PDGF-B oligodeoxynucleotides had no effect. These data suggest that PDGF-BB is involved in regulating growth, but not the degree of branching, of embryonic rat lung.

Animals↗

Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model.

OBJECTIVE: To test the hypothesis that induction of heat shock proteins before the onset of sepsis could prevent or reduce organ injury and death in a rat model of intra-abdominal sepsis and sepsis-induced acute lung injury produced by cecal ligation and perforation. DESIGN: Prospective, blind, randomized, controlled trial. SETTING: University research laboratory. SUBJECTS: One-hundred forty-two adult Sprague-Dawley rats (weight range 200 to 300 g). INTERVENTIONS: Production of intra-abdominal sepsis and exposure to heat stress. Animals were randomly divided into four groups: heated and septic, heated and sham-septic, unheated and septic, and unheated and sham-septic. MEASUREMENTS AND MAIN RESULTS: We evaluated the mortality rate and pathologic changes in lung, heart, and liver at 18 hrs after cecal perforation, at 24 hrs after removal of the cecum, and at 7 days after perforation. Heated animals exhibited a maximum increase in heat shock protein of 72 kilodalton molecular weight protein concentrations in the lungs and heart 6 to 24 hrs after the hyperthermic stress. By 18 hrs after perforation, 25% of the septic, unheated animals had died whereas none of the septic heated animals had died (p < .005). Septic, heated animals showed a marked decrease in 7-day mortality rate (21%) compared with septic unheated animals (69%) (p < .01). Furthermore, septic heated animals showed less histologic evidence of lung and liver damage than septic unheated animals. CONCLUSIONS: These data suggest that thermal pretreatment, associated with the synthesis of heat shock proteins, reduces organ damage and enhances animal survival in experimental sepsis-induced acute lung injury. Although the mechanisms by which heat shock proteins exert a protective effect are not well understood, these data raise interesting questions regarding the importance of fever in the protection of the whole organism during bacterial infection.

Animals↗

Ontogeny of platelet-derived growth factor receptor in fetal rat lung.

There is increasing evidence that platelet-derived growth factor (PDGF) or PDGF-like molecules play a role in fetal lung morphogenesis. Our previous studies demonstrated the presence of PDGF-AA and PDGF-BB homodimers in fetal rat lung. To study further the target cells of PDGF in lung development, immunolocalization studies of PDGF receptors (PDGFR) were conducted on embryonic and fetal rat lung from day 13 to day 21 of gestation (term = 22 days) using two polyclonal PDGFR antibodies, one of which one recognizes both alpha and beta receptors (PDGFR-alpha/beta), while the other is specific for the beta receptor (PDGFR-beta). A similar immunostaining pattern for both antibodies was noted. Immunoreactivity to PDGFR was evident in both epithelial and mesenchymal cells of the embryonic lung bud as early as 13 days gestation. The number of PDGFR immunoreactive cells increased with advancing gestation. Intense immunoreactivity was noted in both epithelial cells and interstitial cells during the saccular stage of lung development. The immunoreactivity to PDGFR was localized to the apical/luminal side of bronchial and distal airway epithelial cells. PDGFR-immunopositive bronchial and vascular smooth muscle cells were detected only during the canalicular and saccular stages of lung development. Immunopositive endothelial cells lining the internal vascular plexuses were observed from days 14-16 of gestation. No PDGFR was detected in endothelial cells of large pulmonary vessels. We conclude that PDGFR are present in airway epithelial cells, interstitial cells, and bronchial and vascular smooth muscle cells and that gestation-dependent up- and down-regulation of PDGFR may play a role in developmental regulation of PDGF bioactivity during lung morphogenesis.

Animals↗

Epitope-specific enhancement of antigen presentation by invariant chain.

The MHC class II-associated invariant chain (Ii) is involved in the intracellular sorting of class II molecules to the endocytic pathway where peptides from processed exogenous antigens are bound, and thereby Ii is thought to enhance antigen presentation. Here we demonstrate that presentation of only one out of five epitopes of a given antigen is augmented by Ii. We have compared the presentation of five different epitopes derived from hen egg white lysozyme (HEL) to Ak-restricted T hybridomas by rat-2 fibroblasts transfected with A alpha k and A beta k (RKK) and RKK cells supertransfected with the mouse invariant chain (RKKI). Only the presentation of the HEL epitope 46-61 was enhanced whereas the presentation of the HEL epitopes 25-43, 34-45, 112-124, and 116-129 was unchanged or even slightly diminished in RKKI cells. The presentation of the epitopes 25-43 and 34-45 was virtually insensitive to the lysosomotropic reagent chloroquine. Brefeldin A (BFA), which inhibits protein egress from the endoplasmic reticulum, blocked the presentation of all epitopes tested in RKKI cells. In contrast, in Ii-negative RKK cells only the presentation of the epitope HEL(46-61) was inhibited by BFA and the presentation of the epitopes 25-43 and 34-45 was only slightly impaired. These findings suggest that Ii may target class II molecules to selected endosomal subcompartments involved in the processing of different peptides derived from an endocytosed antigen. As a result, the enhancement of the class II-restricted presentation in Ii expressing cells appears to be epitope specific rather than antigen specific.

Animals↗

Glucocorticoid prevention of neonatal hypoxic-ischemic damage: role of hyperglycemia and antioxidant enzymes.

Recently, we observed that pre-treatment of neonatal rats with dexamethasone prevents brain damage associated with cerebral hypoxia-ischemia (unilateral carotid occlusion + 3 h hypoxia). Presently, we investigate whether hyperglycemia or an induction of endogenous free radical scavengers explains dexamethasone's neuroprotective effect. Pathological damage was examined in rats maintained hyperglycemic during hypoxia-ischemia by the repeated administration of 10% glucose (10 ml/kg, i.p.) at 0, 1, 2 and 3 h of hypoxia (n = 14) and this damage was compared to that in control (n = 15) or dexamethasone (0.1 mg/kg, i.p., n = 15) treated animals. Despite similar elevations in blood glucose at the end of hypoxia, glucose treated animals had greater damage than dexamethasone treated animals and both of these groups had less damage than controls (volumes of damage of approx. 30.9 +/- 10, 3.4 +/- 2.3 and 60.4 +/- 7.1% of the hemisphere, respectively; P < 0.0001). Anti-oxidant enzyme activities were measured within brains of animals treated with dexamethasone or vehicle (n = 44). Activities of the enzymes catalase, glutathione peroxidase and CuZn- or Mn-superoxide dismutase were similar in both treatment groups, with or without exposure to hypoxia-ischemia. Thus, an induction of antioxidant enzymes does not explain dexamethasone's effects whereas the relative hyperglycemia associated with glucocorticoid treatment may contribute partially. Neither account fully for dexamethasone's protective effect suggesting an additional glucocorticoid mediated mechanism must be involved.

Animals↗

Regulation of phosphatidylcholine synthesis in fetal type II cells by CTP:phosphocholine cytidylyltransferase.

Phosphatidylcholine synthesis increases in fetal rat type II cells during late gestation, as demonstrated by an increased incorporation of radiolabeled palmitate, glycerol, acetate, and choline into phosphatidylcholine. However, the percentage of phosphatidylcholine present in the saturated form remains essentially constant. The developmental profile of the enzymes of the CDP-choline pathway suggests that CTP:choline-phosphate cytidylyltransferase catalyses a rate regulatory step in de novo phosphatidylcholine synthesis by fetal type II cells. When cytidylyltransferase activity is assayed in different subcellular fractions, the greatest increase, as a function of development, is found in microsomes. This developmental increase is accompanied by a shift in subcellular distribution of cytidylyltransferase activity from cytosol to microsomes in fetal type II cells during late gestation. This shift is evident even when cytidylyltransferase activity is assayed in the presence of 0.5 mM phosphatidylcholine/oleic acid (1/1 molar ratio) vesicles. We speculate that either a subcellular translocation of CTP:phosphocholine cytidylyltransferase from cytosol to microsomes or an increase in cytidylyltransferase gene expression are responsible for the developmental increase of de novo phosphatidylcholine synthesis by fetal type II cells.

Animals↗

Assessment of postpreservation rat lung function using a new model for extended venous reperfusion.

Understanding the physiological significance of biochemical events after lung preservation in rats has been hampered by the lack of a suitable model for physiological assessment. We have developed an ex vivo paracorporeal rat lung perfusion model that permits hemodynamic and gas exchange evaluation of lung function. After anesthesia and heparinization, the heart-lung block was removed and the left lung was reperfused for 1 h at a constant flow of 4 ml/min with homologous venous blood drained from the inferior vena cava of the paracorporeal (host) rat. The lung effluent was returned at the same flow rate to the host distal aorta. The model was validated by the assessment of lung function after room temperature ischemia. Animals were allocated into three groups (n = 6) according to the ischemic interval (group 1, 20 min; group 2, 3 h; group 3, 4 h). In groups 1 and 2, PO2, PCO2, mean airway pressure, and pulmonary arterial pressure were within the normal ranges and stable throughout the experiment. In contrast, lungs in group 3 demonstrated higher pulmonary arterial pressure and lower blood effluent PO2 than were found in either group 1 or 2. A significant weight gain during reperfusion was observed only in group 3 (4.23 +/- 0.9 g; P < 0.002). For each lung, the final blood effluent PO2 correlated with the weight gain (R2 = 0.81; P < 0.0001). Our results indicate that this model can be used reliably to detect lung dysfunction after ischemic injury.

Air Pressure↗

Dexamethasone prevents cerebral infarction without affecting cerebral blood flow in neonatal rats.

BACKGROUND AND PURPOSE: We recently demonstrated that pretreatment with the synthetic glucocorticoid dexamethasone prevents hypoxic-ischemic brain damage in neonatal rats. Presently, we examine whether this protective effect of dexamethasone is due to an improvement in local cerebral blood flow. METHODS: Neonatal rats were treated with either vehicle or 0.1 mg/kg i.p. dexamethasone 24 hours before hypoxia-ischemia (right carotid artery occlusion +3 hours of 8% O2). Cerebral blood flow was measured with [14C]iodoantipyrine autoradiography after either 2 (n = 17) or 3 (n = 15) hours of hypoxia-ischemia. Additional animals (n = 20) were perfusion-fixed 3 days after hypoxia-ischemia. The area of cerebral pathological changes was measured from hematoxylin and eosin-stained coronal sections taken at three different levels. RESULTS: Pathological outcome differed between groups. In vehicle-treated rats, sections from anterior, mid, and posterior portions of the cerebrum all had extensive infarction or cellular necrosis ipsilateral to the occlusion (mean areas of damage were 62.6 +/- 10%, 70.2 +/- 9%, and 54.2 +/- 8%, respectively). However, in dexamethasone-treated animals, brain damage in sections at corresponding levels was minimal (0%, 1.6 +/- 2%, and 1.5 +/- 1%, respectively; p < 0.0002). In contrast to the pathological results, cerebral blood flow was equivalent in the dexamethasone- and vehicle-treated groups. After either 2 or 3 hours of hypoxia, cerebral blood flow was reduced 60-80% ipsilateral to the carotid artery occlusion in animals treated with either vehicle or dexamethasone. CONCLUSIONS: Despite ischemic levels of cerebral blood flow, pretreatment with dexamethasone prevents cerebral damage in neonatal rats. Instead of improving local cerebral perfusion, dexamethasone presumably acts via peripheral or central glucocorticoid receptors to produce some alteration in the brain that decreases its susceptibility to hypoxia-ischemia.

Animals↗

Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury.

This study examined the hypothesis that transient, whole-body hyperthermia would reduce lung damage and/or mortality in a previously described animal model of acute lung injury. Normal, adult Sprague-Dawley rats were randomly assigned either to a heated (n = 40) or to a sham-heated (n = 49) group. Heated animals were warmed to 41 to 42 degrees C 18 h before intratracheal instillation of phospholipase A2. Forty-eight hours after phospholipase A2 exposure, the two groups were compared in a blinded fashion for mortality rate, PaO2, AaPO2, lung wet/dry weight ratio, alveolar inflammatory cell number, and lung histopathology. Heated, injured animals exhibited a reduced mortality rate and less lung damage than did unheated animals: mortality (zero versus 27%, p < 0.001); AaPO2 (22 +/- 3 versus 36 +/- 15 mm Hg, p < 0.002); lung lavage cell counts (5.3 +/- 3 versus 16.9 +/- 7 x 10(6)/ml, p < 0.05); lung wet/dry weight ratio (4.1 +/- 0.6 versus 5.1 +/- 0.7, p < 0.025); parenchymal lung injury fraction (0.10 versus 0.51, p < 0.001). Transcription and translation of heat shock proteins (HSP70) were examined by Northern and Western analysis. Pulmonary tissue HSP70 mRNA was elevated 1 h after heating. HSP72 protein levels were increased over baseline levels between 12 and 72 h after whole-body hyperthermia, but they were unchanged in sham-heated animals. These data indicate that thermal pretreatment associated with the induction of HSP72 protein synthesis, attenuates tissue damage and mortality in experimental lung injury.

Animals↗

Fetal lung epithelial cells express receptors for platelet-derived growth factor.

There is increasing evidence to suggest that platelet-derived growth factor (PDGF) or PDGF-like molecules play a role in fetal lung morphogenesis. Our previous studies demonstrated that fetal lung epithelial cells respond mitogenically to exogenous PDGF, while fetal lung fibroblasts respond with increased glycosaminoglycan synthesis. To further study the target cells of PDGF in fetal rat lung, we investigated the presence and nature of PDGF receptors in fetal lung cells. Functional PDGF receptors were expressed on normal epithelial cells of fetal rat lung. All three isoforms of PDGF (AA, AB, and BB) were mitogenic for quiescent epithelial cells. Northern blot and protein analysis demonstrated the presence of PDGF alpha-receptor and PDGF beta-receptor. All isoforms of PDGF enhanced tyrosine kinase activity and stimulated receptor autophosphorylation. In contrast, fetal lung fibroblasts expressed only the PDGF beta-receptor. PDGF-AB and PDGF-BB, but not PDGF-AA, stimulated tyrosine kinase activity. No PDGF isoform was mitogenic for quiescent fibroblasts. However, PDGF-BB stimulated fibroblast proliferation on a collagen type I substratum in the presence of transferrin. Binding experiments with [125I]PDGF-AA and [125I]-PDGF-BB to epithelial cells and fibroblasts confirmed these observations.

Animals↗

Congenital anteroinferior instability treated by Bankart repair.

A subset of patients with symptomatic anteroinferior instability of the shoulder has been recognized. All patients had a history of minimal trauma that was not related to their symptoms. There were 29 men and four women, averaging 29 years of age. Forty-five percent of the patients had failed treatment for associated impingement syndrome. Eleven patients had 17 operations on the shoulder that failed to relieve pain. Preoperative duration of symptoms ranged from four to 130 months (average, 28 months). No Hill-Sachs lesions were present. After a Bankart stabilization, wherein 11 of 33 shoulders had labral tears, pain relief was achieved in 27 of 33 patients. Three additional patients had pain relief after a second-stage acromioplasty. Thus, three of 15 patients with associated impingement syndrome required a second-stage acromioplasty (20%). In summary, 30 of 33 patients had pain relief. There were three failures. Two of the three patients had multidirectional instability. One of these was lost to follow-up evaluation. Another, repaired by a capsular shift, has no further dislocations. One patient required a revision Bankart repair after he sustained a traumatic tear of the capsule ten days after his initial operation; there was no recurrence. The Bankart operation is a worthwhile procedure for congenital unidirectional anteroinferior instability with or without impingement syndrome. It should be done first rather than initially treating the associated impingement.

Adolescent↗